Study protocol of a phase II clinical trial of oral metformin for the intravesical treatment of non-muscle invasive bladder cancer

BACKGROUND: Non-muscle-invasive bladder cancer (NMIBC) is the most common neoplasm of the urinary tract and requires life-long invasive surveillance to detect disease recurrence. Currently, there are no effective oral therapies that delay disease recurrence or progression. We recently demonstrated t...

Descripción completa

Detalles Bibliográficos
Autores principales: Molenaar, Remco J., van Hattum, Jons W., Brummelhuis, Iris S., Oddens, Jorg R., Savci-Heijink, C. Dilara, Boevé, Egbert R., van der Meer, Saskia A., Witjes, J. Fred, Pollak, Michael N., de Reijke, Theo M., Wilmink, Johanna W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873510/
https://www.ncbi.nlm.nih.gov/pubmed/31752752
http://dx.doi.org/10.1186/s12885-019-6346-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873510/
https://www.ncbi.nlm.nih.gov/pubmed/31752752
http://dx.doi.org/10.1186/s12885-019-6346-1

Ejemplares similares